[go: up one dir, main page]

HU0500921D0 - New compounds - Google Patents

New compounds

Info

Publication number
HU0500921D0
HU0500921D0 HU0500921A HUP0500921A HU0500921D0 HU 0500921 D0 HU0500921 D0 HU 0500921D0 HU 0500921 A HU0500921 A HU 0500921A HU P0500921 A HUP0500921 A HU P0500921A HU 0500921 D0 HU0500921 D0 HU 0500921D0
Authority
HU
Hungary
Prior art keywords
new compounds
compounds
new
Prior art date
Application number
HU0500921A
Other languages
Hungarian (hu)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to HU0500921A priority Critical patent/HUP0500921A2/en
Publication of HU0500921D0 publication Critical patent/HU0500921D0/en
Priority to PCT/HU2006/000088 priority patent/WO2007039782A1/en
Publication of HUP0500921A2 publication Critical patent/HUP0500921A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0500921A 2005-10-05 2005-10-05 Tetrazole derivatives, process for their preparation and their use HUP0500921A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0500921A HUP0500921A2 (en) 2005-10-05 2005-10-05 Tetrazole derivatives, process for their preparation and their use
PCT/HU2006/000088 WO2007039782A1 (en) 2005-10-05 2006-10-05 Tetrazole derivatives as modulators of metabotropic glutamate receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0500921A HUP0500921A2 (en) 2005-10-05 2005-10-05 Tetrazole derivatives, process for their preparation and their use

Publications (2)

Publication Number Publication Date
HU0500921D0 true HU0500921D0 (en) 2005-12-28
HUP0500921A2 HUP0500921A2 (en) 2007-07-30

Family

ID=89986318

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500921A HUP0500921A2 (en) 2005-10-05 2005-10-05 Tetrazole derivatives, process for their preparation and their use

Country Status (2)

Country Link
HU (1) HUP0500921A2 (en)
WO (1) WO2007039782A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808777A (en) * 2006-05-05 2008-02-16 Astrazeneca Ab MGLUR5 modulators III
TW200811137A (en) * 2006-05-05 2008-03-01 Astrazeneca Ab mGluR5 modulators II
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
US20120295942A1 (en) 2010-02-01 2012-11-22 Nicholas James Devereux Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
CN102753527B (en) 2010-02-02 2014-12-24 诺华股份有限公司 Cyclohexyl amide derivatives as crf receptor antagonists
BR112013005136B1 (en) 2010-09-02 2018-03-20 Monsanto Technology Llc NEMATICIDE COMPOUNDS AND COMPOSITIONS, AS WELL AS METHODS TO CONTROL NEMATOID PEST
JP2013541553A (en) * 2010-10-21 2013-11-14 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー 1- (Heterocycliccarbonyl) piperidines
AR095330A1 (en) 2013-03-15 2015-10-07 Monsanto Technology Llc AZOLES N-, C-DISPOSED AND COMPOSITIONS AND METHODS TO CONTROL PESTS OF NEMATODES
CA2972294C (en) * 2014-12-24 2018-09-25 National Institute Of Biological Sciences, Beijing Necrosis inhibitors
WO2017002083A1 (en) 2015-07-02 2017-01-05 Wockhardt Limited Nitrogen containing bicyclic compounds and their use in treatment of bacterial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2462289C (en) * 2001-10-04 2010-02-23 Nicholas D. Cosford Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
TW200533664A (en) * 2004-02-18 2005-10-16 Astrazeneca Ab Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
UA82434C2 (en) * 2004-02-18 2008-04-10 Astrazeneca Ab Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists, pharmaceutical composition based thereon
WO2006048771A1 (en) * 2004-11-04 2006-05-11 Addex Pharmaceuticals Sa Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors

Also Published As

Publication number Publication date
WO2007039782A1 (en) 2007-04-12
HUP0500921A2 (en) 2007-07-30

Similar Documents

Publication Publication Date Title
GB0503962D0 (en) Compounds
HK1121755A1 (en) New compounds iii
GB0502418D0 (en) Compounds
EP1934217A4 (en) New compounds ii
GB0502316D0 (en) Compounds
AP2007004220A0 (en) Motilide compounds
HU0500920D0 (en) New compounds
EP1907385A4 (en) Compounds
GB0502299D0 (en) Compounds
GB0502310D0 (en) Compounds
HU0500921D0 (en) New compounds
GB0503961D0 (en) Compounds
GB0505084D0 (en) Compounds
GB0505086D0 (en) Compounds
EP1867650A4 (en) Hydroxymethylboron compounds
HU0501170D0 (en) New compounds
HU0501168D0 (en) New compounds
HU0500886D0 (en) New compounds
HU0500879D0 (en) New compounds
HU0500877D0 (en) New compounds
GB0501985D0 (en) Compounds
GB0505085D0 (en) Compounds
GB0501984D0 (en) Compounds
HU0500878D0 (en) New compounds
HU0501166D0 (en) New compounds

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees